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Clinical manifestations of CNS infections caused by 
enterovirus type 71
Purpose: Enterovirus 71, one of the enteroviruses that are responsible 
for both hand-foot-and-mouth disease and herpangina, can cause 
neural injury. During periods of endemic spread of hand-foot-and-
mouth disease caused by enterovirus 71, CNS infections are also 
frequently diagnosed and may lead to increased complications 
from neural injury, as well as death. We present the results of our 
epidemiologic research on the clinical manifestations of children with 
CNS infections caused by enterovirus 71.
Methods: The study group consisted of 42 patients admitted for CNS 
infection by enterovirus 71 between April 2009 and October 2009 
at the Department of Pediatrics of 5 major hospitals affiliated with 
the Catholic University of Korea. We retrospectively reviewed initial 
symptoms and laboratory findings on admission, the specimen from 
which enterovirus 71 was isolated, fever duration, admission period, 
treatment and progress, and complications. We compared aseptic 
meningitis patients with encephalitis patients.
Results: Of the 42 patients (23 men, 19 women), hand-foot-and-mouth 
disease was most prevalent (n=39), followed by herpangina (n=3), 
upon initial clinical diagnosis. Among the 42 patients, 15 (35.7%) were 
classified as severe, while 27 (64.3%) were classified as mild. Factors 
such as age, fever duration, presence of seizure, and use of intravenous 
immunoglobulin (IVIG) were statistically different between the 2 
groups.
Conclusion: Our results indicate that patients with severe infection 
caused by enterovirus 71 tended to be less than 3 years old, presented 
with at least 3 days of fever as well as seizure activity, and received 
IVIG treatment.
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Introduction
Microbiologically, enteroviruses are a genus of RNA viruses of the 
Picornaviridae family. The genus of enterovirus includes 3 types of 
poliovirus (PV 1-3), 23 types of coxsackievirus A (CVA 1-22 and 24), 
6 types of coxsackievirus B (CVB 1-6), 28 types of echovirus (ECV 
1-7, 9, 11-21, 24-27, and 29-33), as well as other types of enterovirus 
(EV 68-73)
1-3).
Enterovirus is spreads through the fecal-oral route. Gastro  intestinal 
infection is followed by primary proliferation in the pharynx or 
lymph nodes of the small intestine, with spread into various organs in 
the body
4). Clinical symptoms include commonly observed irritation, 
fever, mild pharyngitis and respiratory symptoms with systemic 
symptoms such as headache, vomiting and sometimes diarrhea. Most 
of these symptoms disappear without any complications. However, 
hand-foot-and-mouth disease (HFMD) caused by EV 71 shows 
more severe clinical courses. Prominent neurologic complications 
include meningoencephalomyelitis, poliomyelitis-like paralytic 
disease, opsoclonus-myoclonus syndrome, benign intracranial 
hypertension, and brainstem encephalitis. Some cases are mild and 
reversible but others show rapid progression to neurogenic pulmonary 
edema, pulmonary hemorrhage, and shock-induced sudden death 
with a higher frequency in young children in particular
5). Since the 
late 1990s, severe HFMD cases by EV 71 with subsequent mortality 
have been continuously reported in the West Pacific region including 
Malaysia, Taiwan, Vietnam and China
6-9). In Korea, since the initial 
report that EV 71 was detected in the fatal case of a 12 month old 
infant with severe HFMD with neurological complications in May 
2009
10), severe HFMD cases with neurological complications have 
been consistently observed. Here, we conducted an epidemiologic 
research of clinical manifestations of young children with 
central nervous system (CNS) infection by EV 71 to help in the 
understanding of severe HFMD with neurological complications.
 Materials and methods 
Among the patients who visited 5 medical centers of College of 
the Medicine, the Catholic University of Korea (Seoul St. Mary’s 
Hospital, St. Vincent’s Hospital, Incheon St. Mary’s Hospital, 
Bucheon St. Mary’s Hospital, and Uijeongbu St. Mary’s Hospital) 
from April 2009 to October 2009, 42 patients who were hospitalized 
and treated for clinically severe HFMD or herpangina with CNS 
infection were enrolled in this study. CNS infection was confirmed 
when the patient showed abnormal findings in the CSF study, or in 
radiologic studies such as CT or MRI. Clinical specimens, stools, 
nasopharyngeal swab, and cerebrospinal fluid were collected from 
the patients and sent to the Division of Enteric and Hepatitis Viruses, 
Korea Centers of Disease Control and Prevention. EV71 was detected 
by real time PCR. Medical records including initial symptoms and 
findings at the time of hospitalization, fever duration, hospitalization 
duration, treatment and complications were retrospectively analyzed. 
In addition, 42 subjects were classified into two groups based on the 
severity at presentation: mild patients group and severe patients group. 
The mild patient group included the patients who showed pleocytosis 
in CSF study, who showed normal findings in brain CT or MRI, 
and who recovered without any complications. The severe patient 
group included the patients who showed either, pleocytosis, abnormal 
findings in brain CT or MRI, or severe CNS complications like acute 
flaccid paralysis, ataxia, tremor, motor weakness and coma. The two 
groups were compared for initial clinical manifestations, gender, 
age, febrile period, maximal body temperature, presence of seizure, 
hospitalization duration, test results and immunoglobulin treatment 
in order to identify prognostic factors for severe CNS complications. 
Statistical analysis was conducted by using SPSS, version 12.0. 
Statistical significance was determined as P<0.05 in t-test and chi-
square test.
Results
1. Demographic characteristics and clinical manifes  tations
Among 42 pediatric patients with CNS infection by EV 71, 23 
patients were male and 19 patients were female (gender ratio 1.2:1) 
with a mean age of 3.55 (Table 1).
Age distribution of subjects (range: 6 months-12 years old) was 
10 patients (24%) for each 1-2 years and 3-4 years old age group, 
followed by 5 patients (12%) for 4-5 years old age group, 4 patients 
(9.5%) for 5-6 years old, and 2 patients (4.8%) for 6-7 years old, 
suggesting decreased disease prevalence with increased age (Fig. 1).
Monthly incidence showed 13 patients diagnosed in June, 10 
Table 1. Demographic and Clinical Data of 42 Enterovirus 71 CNS 
Infections
Parameters N (%)
Age (years) 3.55±2.41(median 3.00)
Gender
Male 23 (55%)
Female 19 (45%)
Male:Female 1.2 : 1.0
Initial impression
HFM disease  39 (92.9%)
Herpangina    3 (  7.1%)
Clinical diagnosis
Mild patient group 27 (64.3%)
Severe patient group 15 (35.7%)Korean J Pediatr 2011;54(1):11-16 • DOI: 10.3345/kjp.2011.54.1.11    13
patients in July, and 8 patients in August, showing significantly higher 
incidence in summer (Fig. 2).
Among 42 subjects, HFMD was the first clinical diagnosis for 
39 patients (92.9%), while herpangina was diagnosed in 3 patients 
(7.1%).
Among 42 subjects, 27 patients (64.3%) were classified into the 
mild patient group, and 15 patients (35.7%) were classified into the 
severe patients group (Table 1). For initial clinical symptoms, fever 
(39 patients; 92.9%) was most frequent, followed by headache (24; 
57.1%), vomiting (23; 54.8%), and decreased consciousness (7; 
16.7%). Other symptoms included seizure (4; 9.5%), motor weakness 
(3; 7.1%), and dysuria (1; 2.4%) (Fig. 3).
2. Clinical comparison between mild patient group and 
severe patient group
Among the 15 in the severe patient group, decreased conscious  ness, 
seizure, and motor weakness were observed in 5, 4, and 3 patients, 
respectively, as initial clinical symptoms. However, these symptoms 
were observed in 2, 0, and 0 patients, respectively, out of the 27 
patients in the mild group, indicating a significant difference between 
the two groups with regards to these symptoms (Table 2). The severe 
patient group showed 33.00 months of mean age, 4.00 days of febrile 
period, and 38.35℃   of maximum body temperature, while the mild 
patients group showed 48.48 months of mean age, 2.85 days of 
febrile period, and 38.02℃   of maximum body temperature, showing 
a statistically significant difference in mean age and febrile period 
between the two groups except maximum body temperature (P<0.05) 
(Table 3).
When laboratory test results were compared, the severe patient 
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Fig. 1. Age distribution of the 42 patients with enterovirus 71 CNS infection.
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Fig. 2. Seasonal distribution of the 42 EV71 patients (May 2009-Oct. 
2009).
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Fig. 3. Initial clinical manifestations of enterovirus 71 infection.
Table 2. Initial Clinical Manifestations of 42 Patients with Enterovirus 
Type 71 CNS Infections
Manifestations Mild patient
(n=27, 64.3%)
Severe patient
(n=15, 35.7%) P-value
Initial fever 25 (92.6) 14 (93.3) 0.866
Peak body temperature 38.02±0.86 38.35±1.12 0.295*
Headache 18 (66.7) 6 (40.0) 0.094
Vomiting 14 (51.9) 9 (60.0) 0.611
Mental confusion 2 (7.4) 5 (33.3) 0.031
Seizure (myoclonic jerk) 0 (0.0) 4 (26.7) 0.012
Motor weakness 0 (0.0) 3 (20.0) 0.016
Voiding disturbance 0 (0.0) 1 (6.7) 0.175
*P-value by t-test14      CS Choi, et al. • Enterovirus 71 infection: CNS clinical manifestations
group showed an average CRP level of 1.36 mg/dL, peripheral blood 
white blood cell (WBC) count of 12,760/mm
3, and CSF WBC 
count of 494.64/mm
3, while the mild patient group presented with 
an average CRP level of 4.54 mg/dL, peripheral blood WBC count of 
12,409.26/mm
3, and CSF WBC count of 251.33/mm
3, indicating no 
statistically significant difference between the two groups (Table 3).
With regards to treatment, 8 of 27 patients in the mild group 
(29.6%) received IVIG treatment compared to 13 of 15 patients in 
the severe group (86.7%), showing statistically significant difference 
between two groups (Table 3). Patients in the mild group were 
discharged from the hospital fully recovered, regardless of IVIG 
treatment. In contrast, patients in the severe group were discharged in 
a neurologically complicated state.
3. Enterovirus 71 detection
Positive findings were observed in 35 stool specimens (83.3%), 
16 nasopharyngeal swab specimens (38.1%), and 3 CSF specimens 
(7.1%) out of 42 patients (Table 4). In addition, 7 patients showed 
concomitant positive findings in both stool and nasopharyngeal 
swab specimens, 1 patient was found to be positive in both stool and 
CSF specimens, while 2 patients showed positive results in all stool, 
nasopharyngeal swab, and CSF specimens (Fig. 4).
 Discussion
Enterovirus infection is prevalent worldwide, and the infection 
usually spreads in the warm season, especially summer and autumn, 
when CNS infection by enterovirus increases
5). Based on cases of 
CNS infection by enterovirus in Korea, the infection first occurs 
in March; the incidence rate reaches its peak in July and August, 
and then decreases
11-15). In our study, the monthly incidence rate of 
CNS infection by enterovirus 71 was higher during May to August, 
and then decreased from September (Fig. 2). In most studies, a 
gender-specific difference in incidence rate was observed with higher 
prevalence in males
11-15). Consistent with this observation, the gender 
ratio was 1.2:1 in this study, suggesting a slightly higher prevalence in 
males (Table 1). It has been reported that most patients were 5 years 
old or younger
12), but there are also reports that the highest incidence 
rate was observed in the 4-9 years age group
13) or 5-10 years of age
16). 
This study showed a broad spectrum of age distribution, ranging 
from 6 months to 12 years of age, but 60% of patients were 5 years 
old or younger (1-2 years and 3-4 years age group: 24%, 4-5 years: 
12%) with a mean age of 3.55±2.41, showing that most cases are 
observed in children 5 years old or younger (Table 1).
Most clinical symptoms are asymptomatic or mild, usually with 
non-specific symptoms such as fever, irritation, agitation, sore throat, 
headache, myalgia, vomiting, mild abdominal discomfort, and 
diarrhea
5). The initial clinical symptoms in this study also included 
fever (92.9%), headache (57.1%), and vomiting (54.8%). Since the late 
1990s, HFMD by EV 71 has been reported in various West Pacific 
countries such as Taiwan, China and Vietnam, resulting in many 
severely infected pediatric patients with CNS complications. These 
patients showed myoclonic seizure, motor weakness, and neurologic 
manifestations such as tremor, nystagmus, cranial nerve palsy and 
seizure, which are highly indicatives of brainstem encephalitis
16). 
Some of these patients showed pulmonary edema or pulmonary 
hemorrhage with sudden death due to cardiopulmonary collapse 
or refractory shock
16). Consistently, decreased consciousness, seizure 
and motor weakness as initial clinical symptoms were observed in 
5, 4 and 3 patients, respectively, out of 15 patients with severe CNS 
complications in contrast to 2, 0 and 0 patients, respectively, in the 
mild patient group, suggesting a significant difference (Table 3). 
However, no patient in the severe patient group showed pulmonary 
edema or pulmonary hemorrhage in this study. The risk factors 
Table 4. Enterovirus 71 Yield from Different Specimen Type
Specimen Number tested Number positive Positive rate (%)
Stool 42 35 83.3
Throat swab 42 16 38.1
CSF 42 3   7.1
25
Stool
Throat 
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2
Fig. 4. Enterovirus 71 yield from different specimen types.
Table 3. Comparison of Mild Patient Group and Severe Patient Group
Manifestations
Mild patient
(n=27, 64.3%)
Severe patient
(n=15, 35.7%) P-value
Gender (M:F) 13/14 (1:1.1) 10/5 (2:1) 0.248
Age (months) 48.48±33.09 33.00±15.33 0.046*
Fever duration 2.85±1.23 4.00±1.69 0.015*
Peak BT (℃) 38.02±0.86 38.35±1.12 0.295*
CRP (mg/dL) 4.54±14.82 1.36±2.12 0.283*
WBC (/mm
3) 12,409.26±4,985.98 12,760.00±2,782.83 0.771*
CSF WBC (/mm
3) 251.33±232.84 494.64±814.49 0.291*
IVIG therapy 8 (29.6) 13 (86.7) 0.001
Hospital days 7.07±2.88 14.20±23.12 0.254*
*P-value by t-testKorean J Pediatr 2011;54(1):11-16 • DOI: 10.3345/kjp.2011.54.1.11    15
associated with severe CNS complications by EV 71 include a febrile 
period of 3 days or longer febrile period, 39℃   or higher fever, and 
increased peripheral blood WBC counts
17). In this study, the severe 
patient group with major CNS complications presented at a mean age 
of 33.0 months and 4 days of febrile period, while the mild patient 
group were diagnosed at a mean age of 48.5 months and 3 days of 
febrile period. This significant difference suggests that patients 3 
years of age or younger with 4 days of febrile period or longer may 
show severe symptoms resulting in major neurological complications. 
However, no statistically significant difference was observed with 
regards to maximum body temperature, peripheral blood WBC 
count, CRP level, and CSF WBC count, indicating that these 
parameters may have less significant value as prognostic predictors 
(Table 3). 
The standard protocol for enterovirus diagnosis is based on 
virus culture, but it takes several weeks for confirmation of final 
results with about 50-70% of sensitivity. CSF specimens are usually 
used for the analysis of concurrent CNS complication cases, but 
simultaneous analysis with stool and nasopharyngeal swab specimens 
can increase the sensitivity
5). For nasopharyngeal swab specimens, 
the specimens should be obtained from nasopharyngeal lymphoid 
tissues or mucosal epithelia at an early stage of disease course in order 
to purify viruses. As for stool specimens, viruses can be excreted into 
stools for several weeks, but a higher success rate of virus culture is 
obtained when the specimens are collected within 2 weeks of disease 
onset
18, 19). Generally, the detection rate of enterovirus is highest in 
stool specimens, followed by nasopharyngeal swab specimens, CSF 
specimens, and blood specimens
20). In some cases, however, disease 
progression is rapid, emphasizing the need for faster methods of 
diagnosis
21). The detection rate of enterovirus in this study was highest 
in stool specimens, followed by nasopharyngeal swab specimens, 
and CSF specimens. In contrast to other studies, the detection rate in 
CSF specimens was low in this study, which may be due to delayed 
CSF study and consequent delayed transportation of CSF specimens, 
prolonged storage of specimens prior to transportation, or problems 
during specimen transportation.
The administration of high dose intravenous immunoglobulin 
(IVIG) is recommended for the treatment of severe enterovirus CNS 
infection, and prompt IVIG administration based on early diagnosis 
of severe CNS infection is required for favorable outcomes
5, 17, 21). 
In this study, 13 of 15 patients (86.7%) in the severe patient group 
received IVIG treatment while 8 of 27 patients in the mild group 
(29.6%) received IVIG. There was statistically significant difference 
with regards to IVIG treatment. However, IVIG may be used in mild 
patient group to prevent rapid progression to severe clinical courses. 
With increased overseas travel and use of child care facilities, the 
risks of imported EV 71 infection and spread are extremely high. In 
particular, child care centers, kindergartens and schools crowded with 
children are vulnerable to viral transmission. In 2008, an expanded 
enterovirus infection resulted in the temporary closing of classes 
in many schools in Singapore
22). In 2009, severe EV 71-induced 
HFMD with neurological complications was reported in Korea. We 
are continuously at risk of repeated infections, but no nationwide 
epidemiological study has been conducted, with many unresolved 
problems pertaining to early diagnosis. Thus, close nationwide 
epidemiological investigations and clinical studies of severe HFMD 
remain to be conducted in the future. 
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